Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1975 1
1976 1
1991 1
1992 1
1993 1
1994 3
1995 3
1996 3
1997 5
1998 2
1999 13
2000 9
2001 12
2002 11
2003 9
2004 10
2005 10
2006 9
2007 9
2008 6
2009 2
2010 2
2011 1
2012 3
2013 2
2014 3
2016 1
2017 2
2019 1
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11642380

137 results
Results by year
Filters applied: . Clear all
Page 1
Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM. Mori K, et al. Retina. 2001;21(5):499-508. doi: 10.1097/00006982-200110000-00013. Retina. 2001. PMID: 11642380
PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T. Obana A, et al. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2639-45. Invest Ophthalmol Vis Sci. 2001. PMID: 11581211
Intraocular biodistribution of mono-L-aspartyl chlorin e6 in a primate choroidal neovascularization model.
Mori K, Kanai K, Peyman GA, Yoneya S. Mori K, et al. Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):142-7. doi: 10.3928/15428877-20070301-09. Ophthalmic Surg Lasers Imaging. 2007. PMID: 17396695
Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
Huang Y, Xu G, Peng Y, Lin H, Zheng X, Xie M. Huang Y, et al. J Ocul Pharmacol Ther. 2007 Aug;23(4):377-86. doi: 10.1089/jop.2006.0135. J Ocul Pharmacol Ther. 2007. PMID: 17803437
Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA. Nakashizuka T, et al. Retina. 2001;21(5):493-8. doi: 10.1097/00006982-200110000-00012. Retina. 2001. PMID: 11642379
Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM. Mori K, et al. Ophthalmology. 1999 Jul;106(7):1384-91. doi: 10.1016/S0161-6420(99)00729-0. Ophthalmology. 1999. PMID: 10406627
Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.
Obana A, Gohto Y, Kanai M, Nakajima S, Kaneda K, Miki T. Obana A, et al. Arch Ophthalmol. 2000 May;118(5):650-8. doi: 10.1001/archopht.118.5.650. Arch Ophthalmol. 2000. PMID: 10815157
Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Husain D, et al. Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2322-31. Invest Ophthalmol Vis Sci. 1999. PMID: 10476799
Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
Obana A, Gohto Y, Kaneda K, Nakajima S, Takemura T, Miki T. Obana A, et al. Lasers Surg Med. 1999;24(3):209-22. doi: 10.1002/(sici)1096-9101(1999)24:3<209::aid-lsm6>;2-l. Lasers Surg Med. 1999. PMID: 10229152
Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F. Berdugo M, et al. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767. Invest Ophthalmol Vis Sci. 2008. PMID: 18385085
137 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page